Enrique Mendoza-Ramirez

Mr. Enrique Mendoza-Ramirez

Instituto Nacional de Enfermedades Respiratorias, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2025 in Viruses
Verified
Journal Article
Open access
PDF file
JVJoel Armando Vazquez-Perez
Joel Armando Vazquez-Perez
CWCladia Wong
Cladia Wong
MSMario Solís-Hernández
Mario Solís-Hernández
EBEduardo Becerril
Eduardo Becerril
GBGisela Barrera
Gisela Barrera
CHCarmen Margarita Hernández-Cardenas
Carmen Margarita Hernández-Cardenas
In April 2024, the Instituto Nacional de Enfermedades Respiratorias of Mexico City identified a case of unsubtypeable Influenza A in a 58-year-old immunocompromised patient with renal failure due to diabetic nephropathy and bacterial peritonitis. Through sequencing the M, NS, NA, NP, and HA complete segments, we identified an H5N2 influenza virus with identity of 99% with avian influenza A(H5N2) from Texcoco, Mexico, in 2024. This case is the first reported with direct evidence of human infection caused by the H5N2 influenza virus; the relationship of the virus with the severity of his condition remains unknown.

30 January 2026 in Viruses
Verified
Journal Article
Open access
PDF file
PVPatricia Volkow
Patricia Volkow
MVMarco Villanueva-Reza
Marco Villanueva-Reza
SÁSantiago Ávila-Ríos
Santiago Ávila-Ríos
EMEnrique Mendoza-Ramirez
Enrique Mendoza-Ramirez
AVAmérica Citlali Vera-Jimenez
América Citlali Vera-Jimenez
JVJoel Armando Vazquez-Perez
Joel Armando Vazquez-Perez
Immunocompromised patients, including those with advanced HIV infection, hematologic malignancies treated with anti-CD20 monoclonal antibodies, or combined immunodeficiencies, are at increased risk of persistent SARS-CoV-2 infection. While long-term viral shedding has been described in these patients, the extent and nature of intra-host viral evolution during long-term infection remain insufficiently documented. In this study, we report longitudinal genomic analyses of SARS-CoV-2 from three immunocompromised individuals with persistent COVID-19: (i) a female patient with follicular lymphoma receiving bendamustine-rituximab therapy with 9 months of persistence, (ii) a male patient with advanced HIV infection following prolonged antiretroviral therapy interruption with 10 months of persistence, and (iii) a female patient with Good’s Syndrome characterized by combined humoral and cellular immune deficiency with apparently four years of persistence. Replication-competent virus was detected over extended periods. Sequential whole-genome sequencing revealed the gradual accumulation of non-synonymous mutations across multiple viral genes, consistent with ongoing viral replication and intra-host diversification in the absence of effective immune control. Although based on a limited number of cases, these findings provide descriptive evidence that persistent SARS-CoV-2 infection in immunocompromised hosts can be associated with sustained viral evolution. This work highlights the importance of continued virological monitoring in selected patients with prolonged infection and contributes to the understanding of SARS-CoV-2 dynamics in settings of impaired immunity.

27 May 2026 in Viruses
Verified
Journal Article
Open access
PDF file
BTBlanca Taboada
Blanca Taboada
SZSelene Zarate
Selene Zarate
JMJosé Esteban Muñoz Medina
José Esteban Muñoz Medina
JVJoel Armando Vazquez-Perez
Joel Armando Vazquez-Perez
ASAlejandro Sanchez-Flores
Alejandro Sanchez-Flores
CACarlos Arias
Carlos Arias
Seasonal influenza circulation was profoundly disrupted during the COVID-19 pandemic, resulting in an unprecedented global decline in viral activity and genetic diversity. As non-pharmaceutical interventions gradually relaxed, influenza viruses re-emerged in multiple regions in 2022; however, genomic data from Latin America remain limited, particularly for the first post-pandemic season. In this study, we analyzed the epidemiological, genomic, and evolutionary patterns of influenza A and B viruses circulating in Mexico between June 2018 and June 2023, with a specific focus on the first post-pandemic season (June 2022–June 2023). More than 90% of the influenza virus genomes available from Mexico for this post-pandemic period were generated in this study, while data from earlier seasons were used for contextualization. Following a near-complete absence of influenza circulation during 2020–2021, viral activity re-emerged in late 2021 and intensified during 2022–2023. Post-pandemic circulation in Mexico was dominated by influenza A(H3N2), with a lower contribution from A(H1N1)pdm09 and a delayed re-emergence of B/Victoria; B/Yamagata was not detected. Genomic analyses revealed rapid lineage turnover after the pandemic, characterized by the predominance of post-pandemic clades and reduced genetic diversity compared with pre-pandemic seasons. Phylogenetic analyses indicated multiple introductions and strong regional connectivity across North and South America.